FORMULATION, DEVELOPMENT AND EVALUATION OF ANTI-IMPLANTATION ACTIVITY OF INTRAUTERINE SYSTEM OF CENTCHROMAN (SAHELI) USING WISTAR ALBINO RATS

 

{ DOWNLOAD AS PDF }

ABOUT AUTHORS:
Himani Devliyal*, S.S Agarwal
Department of Pharmacology,
Delhi Institute of Pharmaceutical Sciences and Research, Delhi University, New Delhi
himanidevliyal@gmail.com

ABSTRACT
Centchroman – A Non-steroidal, post-coital anti-implantation drug which is generally popular as SAHELI is one of the best agents available. The fundamental aim of this study  was to formulate such an Intra-uterine System of Centchroman which should be safe and acceptable. This new drug delivery system surpasses the first pass metabolism, thus increasing the bioavailability and reducing the drug load. This formulation delivered the drug upto 21 days. Polylactic-co-glycolic acid served as the best fit polymer for delivering the drug. The best optimized formulation was selected and subjected to stability studies.  The effect of the foreign bodies was also observed on the fertility, mating behaviour and estrous cycle of the rats along with anti-implantation activity of the IUS. This formulation was tested on Wistar albino rats and is proved to be safe at the optimized dose level. The formulation exhibited pre-implantation loss of 100% and post-implantation loss of 0% in Wistar albino rats at a particular dose when delivered on 1st day and 4th day post-coital. Experimental part on animals showed that any foreign body, if put inside the uterus would not affect the fertility unless the size is more than 6mm. Results showed that 3mm objects had no effect on fertility. The foreign bodies and the IUS showed neither any alteration in the estrous cycle nor on the mating behavior of the animals.

REFERENCE ID: PHARMATUTOR-ART-2167

PharmaTutor (ISSN: 2347 - 7881)

Volume 2, Issue 5

Received On: 20/03/2014; Accepted On: 27/03/2014; Published On: 01/05/2014

How to cite this article: H Devliyal, SS Agarwal; Formulation, Development and Evaluation of Anti-Implantation Activity of Intrauterine System of Centchroman (Saheli) using Wistar Albino Rats; PharmaTutor; 2014; 2(5); 128-132

INTRODUCTION
In the recent years, considerable attention has been focused on enhancing the drug absorption and efficacy by redesigning the delivery process rather than the drug molecules or chemical entities. This has led to the development of Novel Drug Delivery System10. There are several advantages of Intra-uterine delivery as opposed to oral delivery, for e.g. drug avoid the hostile environment of the GIT (the action of pH and enzyme) and avoid first pass metabolism (the drug is directly been delivered to the uterine cavity and thus to systemic circulation) . In addition, drug delivery by the IUS can show sustained plasma profile over long period of time.  This could minimize the risk of fluctuation of drug plasma level. Other attractive feature is that it can be inserted once and can be terminated when the lady wants to conceive. The contraceptive options present today are oral pills, IUDs, condoms, vaginal creams etc. Amongst them the most acceptable method of choice is either the oral pills or intrauterine devices8; still there lies a large unmet need for contraception.

Thus our fundamental aim for carrying out this research work was to formulate such a novel delivery system which should be safe and acceptable4. For that purpose we have chosen centchroman9 which is a Non-steroidal post- coital contraceptive agent of established anti-implantation activity2. This drug candidate served a great fit to our set criteria for research work. This property has boosted its efficacy with minimizing side effects. Using centchroman in the IUS form is a novel thought and delivering the same for 21 days was an add-on feature to the formulation. For the better safety and use the drug was dispersed in the polymer PLGA uniformly. PLGA is a biodegradable polymer, therefore the device need not to be removed from the body when not required further, thus increasing patient compliance. Moreover the polymer was found to be highly compatible with the drug. This formulation is tested on Wistar albino rats and is proved to be safe at the optimized dose level. The efficacy and safety of the IUS was compared with the oral drug5. During the Pharmacodynamic evaluation of the IUS the effect of presence of foreign bodies was also figured out through the same1. The present study was undertaken to evaluate the effect of IUS on the fertility. The study was done to determine the effect of time, site and length of foreign bodies on fertility. As foreign bodies, Nylon thread, surgical suture and leaf petiole were selected. These were placed in the lower segment of the right uterine horn. The distance of the vagina from the cervix was optimized previously. The piston was allowed to push the patch upto the lower segment of the horn. The length of the foreign agent taken ranged from 3mm to 6mm.

MATERIALS AND METHODS
Animals:
Wistar albino  female rats having weight between 150-200 g were used in the present study. Our Protocol No.7 (IAEC) of the year 2006-07, was approved by “Institutional animal ethics committee” (IAEC), as per the norms of CPCSEA (Committee for the Purpose of Control & Supervision of Experimentation on Animals). Healthy albino rats were obtained from animal house, of DIPSAR, Pushp Vihar, New Delhi (Registration no. 215/CPCSEA 1ST June 2000). All the animals were kept under identical conditions of food, water, and temperature at DIPSAR animal house.

Materials: The drug sample of centchroman was obtained as gift sample from Hindustan Latex Ltd. Batch No. CENT F002, Manufacturing date Oct /2006. UV spectroscopy, FTIR and DSC authenticated the drug sample.PLGA used was provided by Supreme combine Bombay. Animal ultrasound machine was used during the study for evaluating the implants of the animals.

Methods: Centchroman sample was authenticated byUV, FTIR and DSC. Standard curve of Centchroman was prepared and the absorbance was obtained at 278nm. Matrix type IUDDS was prepared using solvent casting technique in which the drug was dispersed uniformly in the polymer that is PLGA3. 2% propylene glycol was added to the formulation as a plasticizer. The formed film containing the dispersed drug was stripped off and kept in oven at 400C for 3-4 hrs. Total of five formulations were prepared, out of which one was optimized which showed the highest release rate among all. The formulation was tested for physical parameters like thickness, weight, area volume and uniformity assay. The dissolution studies were carried out in 230 ml of phosphate buffer pH 7.2 at a temperature of 37ºC at a constant speed of 50 rpm. The developed film was subjected to accelerated stability testing according to the guidelines prescribed by International Conference on Harmonization (ICH). The films were kept at 40ºC temperature and 75% relative humidity. The films were packaged with butter paper and aluminum foil (Blister pack). These packs were then put into a resealable plastic bag and subjected to 40º C at 75 % RH and 25º C at 65 % RH in an incubator. The films were analysed for Drug release profile and Polymer-drug interaction/Polymer-polymer interaction (FTIR & DSC)

Further in-vivo animal study was conducted which accounted for the efficacy and safety of the system formulated. In addition a partner study was also conducted to determine the effect of time, site and length of foreign bodies on fertility. As foreign bodies, Nylon thread, surgical suture and leaf petiole were taken. These were placed in the lower segment of the right uterine horn. The patch was delivered through the vagina of the animal .For that a polyethylene tough tube of diameter 2mm was used inside which the patch was rolled in. The patch was then pushed through another tube which acted as a piston. The distance of the vagina from the cervix was optimized previously which is about 2.8 ± 0.5 cm .The piston was allowed to push the patch upto the lower segment of the horn. The position of the patch was confirmed by looking inside the uterus of the few animals slaughtered after insertion. The length of the foreign bodies varied from 3mm to 6mm also.6, 7

RESULTS:
Mean of readings of the same specimen was taken as actual value. Data were presented as mean±SEM. One-way ANOVA followed by Tukey test was used to compare mean values of the groups.

The dissolution of the optimized formulation showed a release of 5.12,19.31, 45.66, 80.96, and 98.66 % ofthe drug in 1, 18, 108, 263 and 479 hr respectively. The regression coefficient value of Higuchi’s plots was calculated to be 0.9944.Thus the formulation was following higuchi’s release pattern giving it a confirmation of sustain release.(fig-1)

Figure 1 Depicts mean % cumulative  release of  the optimised formulation

NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.

SUBMIT YOUR ARTICLE/PROJECT AT articles@pharmatutor.org

Subscribe to Pharmatutor Alerts by Email

FIND OUT MORE ARTICLES AT OUR DATABASE


Pages

FIND MORE ARTICLES